30
300888.SHE Winner Medical Co Ltd
- Market cap
- CNY 17.9B
- P/E
- 22.2x
- P/B
- 1.49x
- ROE
- 8.7%
- Dividend yield
- 3.40%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 300888.SHE undervalued?
Graham number300888.SHE trades 21.1% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Winner Medical Co Ltd fundamental analysis
No fundamental analysis for Winner Medical Co Ltd yet.
Winner Medical Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Winner Medical Co Ltd
Winner Medical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of disposable medical products in China and internationally. It operates in two segments, Medical Consumables and Consumer Products. The company offers wound care solutions, including gauzes, bandages, adhesive and film dressings, cotton and non-woven products, basic kits, liquid skin protectants, debridement and exudate management products, anti-adhesion woun…
Full company profileWinner Medical Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Winner Medical Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 2.56B | 3.50B | 3.84B | 4.57B | 12.5B | 8.04B | 11.4B | 8.19B | 8.98B | 10.9B | 10.9B |
| Gross Profit | 1.23B | 1.65B | 1.87B | 2.34B | 7.32B | 3.92B | 5.01B | 3.79B | 4.10B | 5.22B | 5.25B |
| Operating Income | 492M | 516M | 496M | 642M | 4.53B | 1.48B | 1.98B | 818M | 915M | 1.31B | 1.36B |
| EBITDA | 544M | 607M | 609M | 756M | 4.67B | 1.66B | 2.24B | 1.13B | 1.32B | 1.77B | 1.27B |
| Net Income | 410M | 427M | 425M | 546M | 3.81B | 1.24B | 1.65B | 580M | 695M | 768M | 988M |
| EPS | 0.79 | 0.82 | 0.81 | 1.04 | 6.99 | 2.08 | 2.79 | 0.98 | 1.19 | 1.32 | 1.69 |
| Balance Sheet | |||||||||||
| Total Assets | 2.30B | 3.39B | 3.96B | 4.53B | 13.5B | 13.3B | 18.3B | 17.1B | 18.4B | 18.4B | 18.9B |
| Total Liabilities | 647M | 1.41B | 1.30B | 1.37B | 3.10B | 2.58B | 6.05B | 5.00B | 6.52B | 6.11B | 6.70B |
| Shareholders' Equity | 1.65B | 1.97B | 2.66B | 3.16B | 10.4B | 10.7B | 11.7B | 11.5B | 11.2B | 11.5B | 11.4B |
| Cash & Short-term Investments | 329M | 450M | 404M | 481M | 8.29B | 7.40B | 8.91B | 7.56B | 4.33B | 1.59B | 1.38B |
| Total Debt | 60.0M | 395M | 300M | 254M | 514M | 382M | 2.62B | 1.96B | 2.46B | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 450M | 358M | 468M | 600M | 4.77B | 872M | 2.98B | 1.06B | 1.27B | 1.67B | - |
| Capital Expenditure | 288M | 530M | 638M | 447M | 573M | 743M | 1.20B | 753M | 901M | 648M | 851M |
| Free Cash Flow | 162M | -172M | -170M | 153M | 4.19B | 128M | 1.78B | 310M | 365M | 1.02B | -89.1M |
| Ratios | |||||||||||
| ROE | 24.8% | 21.6% | 16.0% | 17.3% | 36.7% | 11.6% | 14.1% | 5.0% | 6.2% | 6.7% | 8.7% |
| ROA | 17.8% | 12.6% | 10.7% | 12.1% | 28.2% | 9.3% | 9.0% | 3.4% | 3.8% | 4.2% | 5.2% |
| Net Profit Margin | 16.0% | 12.2% | 11.1% | 11.9% | 30.4% | 15.4% | 14.5% | 7.1% | 7.7% | 7.0% | 9.0% |
| Debt to Equity | 0.04x | 0.20x | 0.11x | 0.08x | 0.05x | 0.04x | 0.22x | 0.17x | 0.22x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Winner Medical Co Ltd dividends
- Dividend yield
- 3.40%
- Forward dividend
- 0.80 CNY
- Payout ratio
- 79.0%
- Ex-dividend date
- Sep 2, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 607M | 1.04 | 79.0% |
| 2024 | CNY 413M | 0.71 | 59.3% |
| 2023 | CNY 822M | 1.39 | 141.6% |
| 2022 | CNY 378M | 0.64 | 22.9% |
| 2021 | CNY 768M | 1.29 | 61.9% |
| 2020 | CNY 102M | 0.19 | 2.7% |
| 2019 | CNY 43.0M | 0.08 | 7.9% |
| 2018 | CNY 58.4M | 0.11 | 13.7% |
| 2017 | CNY 114M | 0.22 | 26.8% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.4:1 on Jun 2, 2023.
Who owns Winner Medical Co Ltd
- Insiders 71.84%
- Institutions 3.35%
- Public & others 24.81%
- Shares outstanding 583M
- Free float 161M
Winner Medical Co Ltd company profile
- Company name
- Winner Medical Co Ltd
- Ticker
- 300888.SHE
- ISIN
- CNE1000047Z8
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 15,855
- Fiscal year end
- December
- Address
- Building 2, Huilong Business Center, Shenzhen, China, 518131
- Phone
- 86 755 2813 8888
- Website
- winnermedical.com
About Winner Medical Co Ltd
Winner Medical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of disposable medical products in China and internationally. It operates in two segments, Medical Consumables and Consumer Products. The company offers wound care solutions, including gauzes, bandages, adhesive and film dressings, cotton and non-woven products, basic kits, liquid skin protectants, debridement and exudate management products, anti-adhesion wound care, scar repair products, antimicrobial solutions, and biological active and compression treatment products; and operating room solutions, such as masks, gloves, protective apparel, surgical gowns and drapes, speciality drapes and packs, operating room solution accessories, general surgical kits and trays, and surgical consumables for pets. It also provides home care solutions comprising wound care products, which includes adhesive and silicone bandages, as well as first aid kits; and personal care products, such as incontinence, cosmetics, other cotton products, and foot, daily, sports, ear, nose, and throat care products, as well as hygiene products comprising panty liners, sanitary napkins, tampons, breast and maternity pads, disposable underwear, and baby diapers. In addition, the company is involved in technology promotion services; engineering and technology research and experimental development; manufacturing of medical instruments, equipment, and devices; software and information technology services; production of rubber and chemical products; and trading and consulting services. It sells its products under the Winner Medical, Purcotton, and PureH2B brands through sales teams, hospitals, e-commerce, and pharmacy and chain stores. The company serves the hospital, pharmacy, PPE, consumer, and industrial field industries. It exports its products. The company was founded in 1991 and is headquartered in Shenzhen, China. Winner Medical Co., Ltd. is a subsidiary of Winner Group Limited.
Winner Medical Co Ltd management
7- Mr. Jianquan LiChairman, CEO & GM · born 1957
- Mr. Xiuyuan FangNon-Independent Director, Deputy GM & CFO · born 1968
- Ms. Liao MeizhenNon-Independent Director · born 1982
- Ms. Huixuan ChenDeputy GM & Secretary · born 1982
- Mr. Guan Lai LiaoDeputy General Manager · born 1982
- Ms. Xia YanDeputy General Manager · born 1975
- Yan ZhaoAccounting Supervisor